Alzheimer's Disease
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
3397
|
1843
|
0.120 |
None |
0.500 |
2 |
2
|
2014 |
2018 |
Heart failure
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1499
|
201
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2018 |
Congestive heart failure
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1760
|
165
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2018 |
Diabetes Mellitus, Non-Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
3134
|
2672
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Degenerative polyarthritis
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
1827
|
247
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Cerebral atrophy
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
454
|
44
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
ST segment elevation myocardial infarction
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
264
|
16
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Chronic Kidney Diseases
|
group |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
1074
|
306
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Brain atrophy
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
182
|
46
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Blood Protein Measurement
|
phenotype |
|
Laboratory Procedure
|
1156
|
2575
|
0.100 |
None |
1.000 |
2 |
3
|
2018 |
2018 |
Glucose tolerance test
|
phenotype |
|
Laboratory Procedure
|
17
|
28
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
C-reactive protein measurement
|
phenotype |
|
Laboratory Procedure
|
135
|
624
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Glucagon measurement
|
phenotype |
|
Laboratory Procedure
|
2
|
2
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
High density lipoprotein measurement
|
phenotype |
|
Laboratory Procedure
|
545
|
1440
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Vitamin D3 measurement
|
phenotype |
|
Laboratory Procedure
|
14
|
51
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Vitamin D measurement
|
phenotype |
|
Laboratory Procedure
|
14
|
51
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Presenile dementia
|
disease |
Nervous System Diseases; Mental Disorders
|
Mental or Behavioral Dysfunction
|
718
|
159
|
0.010 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Mental deterioration
|
phenotype |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
508
|
121
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Impaired cognition
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1630
|
348
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Dementia
|
disease |
Nervous System Diseases; Mental Disorders
|
Mental or Behavioral Dysfunction
|
816
|
176
|
0.010 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Malignant neoplasm of endometrium
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
1235
|
197
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Cartilaginous exostosis
|
disease |
Neoplasms; Musculoskeletal Diseases
|
Neoplastic Process
|
47
|
2
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Osteosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2283
|
178
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Secondary malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
1370
|
20
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Metastatic osteosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
51
|
5
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |